Personal information

United States

Activities

Employment (4)

Weill Cornell Medicine: New York, US

2022 to present | Clinical Fellow (Hematology & Oncology)
Employment
Source: Self-asserted source
Joshua Fein

UCONN Health: Farmington, Connecticut, US

2019-06 to present
Employment
Source: Self-asserted source
Joshua Fein

Sheba Medical Center at Tel Hashomer: Tel Hashomer, IL

2015-11-01 to 2019-05 | Research (Bone Marrow Transplantation)
Employment
Source: Self-asserted source
Joshua Fein

Dana-Farber/Harvard Cancer Center: Boston, MA, US

2013-07-01 to 2015-07-31 | Clinical Research Coordinator (Lymphoma Group)
Employment
Source: Self-asserted source
Joshua Fein

Education and qualifications (3)

Tel Aviv University Sackler Faculty of Medicine: Tel Aviv, IL

2015-09-01 to present | MD Candidate
Education
Source: Self-asserted source
Joshua Fein

Hochschule für Musik Karlsruhe: Karlsruhe, Baden-Württemberg, DE

2009-02-01 to 2011-04-01 | M. Mus. (Gesang)
Education
Source: Self-asserted source
Joshua Fein

University of Rochester Eastman School of Music: Rochester, NY, US

2004-09-01 to 2008-05-01 | B. M. (Voice)
Education
Source: Self-asserted source
Joshua Fein

Works (24)

A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation

Leukemia & Lymphoma
2024-12-06 | Journal article
Contributors: Joshua A. Fein; Agnes McAuliffe; Kimberly Fischer; Owen Brady; Sean M. Devlin; Silvia Willumsen; Gonca Ozcan; Pat Montanaro; Yelena Pristyazhnyuk; Joseph DiGiuseppe et al.
Source: check_circle
Crossref

Wild-Type p53 Overexpression in NPM1-Mutated AML: Potential Implications for Disease Biology and Therapy Response

2024-10-09 | Preprint
Contributors: Paul Barone; Siarhei Dzedzik; Ashley Kleinman; Christopher Chin; Cem Meydan; Itzel Valencia; Mayumi Sugita; Monica Guzman; Joshua Fein; Justin Kaner et al.
Source: check_circle
Crossref

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Blood Advances
2024-08-13 | Journal article
Contributors: Mateo Mejia Saldarriaga; Darren Pan; Caitlin Unkenholz; Tarek H. Mouhieddine; Juan Esteban Velez-Hernandez; Katherine Engles; Joshua A. Fein; Jorge Monge; Cara Rosenbaum; Roger Pearse et al.
Source: check_circle
Crossref

Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study

Bone Marrow Transplantation
2024-03 | Journal article
Contributors: Ilan Youngster; Adi Eshel; Mika Geva; Ivetta Danylesko; Israel Henig; Tsila Zuckerman; Shalev Fried; Ronit Yerushalmi; Noga Shem-Tov; Joshua A. Fein et al.
Source: check_circle
Crossref

Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML

Blood Advances
2024-02-13 | Journal article
Contributors: Joshua A. Fein; Roni Shouval; Elizabeth Krieger; Stephen R. Spellman; Tao Wang; Henning Baldauf; Katharina Fleischhauer; Nicolaus Kröger; Mary Horowitz; Martin Maiers et al.
Source: check_circle
Crossref

Under AI’s lens: spotting mutations visually

Blood Advances
2024-02-13 | Journal article
Contributors: Joshua A. Fein; Sanjay S. Patel
Source: check_circle
Crossref

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

Blood Advances
2023-05-23 | Journal article
Contributors: Joshua A. Fein; Roni Shouval; Jacques-Emmanuel Galimard; Myriam Labopin; Gérard Socié; Jürgen Finke; Jan J. Cornelissen; Ram Malladi; Maija Itälä-Remes; Patrice Chevallier et al.
Source: check_circle
Crossref

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Leukemia
2023-01 | Journal article
Contributors: Ana Alarcon Tomas; Joshua A. Fein; Shalev Fried; Jessica R. Flynn; Sean M. Devlin; Warren B. Fingrut; Theodora Anagnostou; Anna Alperovich; Nishi Shah; Ellen Fraint et al.
Source: check_circle
Crossref

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

Blood Advances
2022-03-08 | Journal article
Contributors: Roni Shouval; Joshua A. Fein; Christina Cho; Scott T. Avecilla; Josel Ruiz; Ana Alarcon Tomas; Miriam Sanchez-Escamilla; Nerea Castillo Flores; Lucrecia Yáñez; Juliet N. Barker et al.
Source: check_circle
Crossref

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy

Journal of Clinical Oncology
2022-02-01 | Journal article
Contributors: Roni Shouval; Ana Alarcon Tomas; Joshua A. Fein; Jessica R. Flynn; Ettai Markovits; Shimrit Mayer; Aishat Olaide Afuye; Anna Alperovich; Theodora Anagnostou; Michal J. Besser et al.
Source: check_circle
Crossref

Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis

Blood Advances
2022-01-25 | Journal article
Contributors: Adi Eshel; Itai Sharon; Arnon Nagler; David Bomze; Ivetta Danylesko; Joshua A. Fein; Mika Geva; Israel Henig; Avichai Shimoni; Tsila Zuckerman et al.
Source: check_circle
Crossref

High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphoma

Bone Marrow Transplantation
2021-11-29 | Journal article
Contributors: Mika Geva; Angharad Pryce; Roni Shouval; Joshua A. Fein; Ivetta Danylesko; Noga Shem-Tov; Ronit Yerushalmi; Avichai Shimoni; Richard Szydlo; Jiri Pavlu et al.
Source: check_circle
Crossref

Machine learning and artificial intelligence in haematology

British Journal of Haematology
2021-01 | Journal article
Contributors: Roni Shouval; Joshua A. Fein; Bipin Savani; Mohamad Mohty; Arnon Nagler
Source: check_circle
Crossref

LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation
2020-09-17 | Journal article
Contributors: Roni Shouval; Omer Teper; Joshua A. Fein; Ivetta Danylesko; Noga Shem Tov; Ronit Yerushalmi; Abraham Avigdor; Elena Vasilev; Hila Magen; Arnon Nagler et al.
Source: check_circle
Crossref

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

Blood Advances
2020-07-14 | Journal article
Contributors: Roni Shouval; Adi Eshel; Bar Dubovski; Amir A. Kuperman; Ivetta Danylesko; Joshua A. Fein; Shalev Fried; Mika Geva; Elizaveta Kouniavski; Hadar Neuman et al.
Source: check_circle
Crossref

Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis

Bone Marrow Transplantation
2020-01-28 | Journal article
Contributors: Roni Shouval; Yakov Vega; Joshua A. Fein; Ivetta Danylesko; Noga Shem Tov; Ronit Yerushalmi; Marta Sobas; Anna Czyż; Arnon Nagler; Avichai Shimoni
Source: check_circle
Crossref

External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation

Blood Advances
2019-06-25 | Journal article
Contributors: Roni Shouval; Joshua A. Fein; Aniela Shouval; Ivetta Danylesko; Noga Shem-Tov; Maya Zlotnik; Ronit Yerushalmi; Avichai Shimoni; Arnon Nagler
Source: check_circle
Crossref

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality

Biology of Blood and Marrow Transplantation
2018-08 | Journal article
Contributors: Roni Shouval; Cornelis N. de Jong; Joshua Fein; Annoek E.C. Broers; Ivetta Danylesko; Avichai Shimoni; Marloes R. Reurs; Adája E. Baars; Niels van der Schaft; Arnon Nagler et al.
Source: check_circle
Crossref

An integrative scoring system for survival prediction following umbilical cord blood transplantation in acute leukemia

Clinical Cancer Research
2017 | Journal article
EID:

2-s2.0-85033595794

Contributors: Shouval, R.; Ruggeri, A.; Labopin, M.; Mohty, M.; Sanz, G.; Michel, G.; Kuball, J.; Chevallier, P.; Al-Seraihy, A.; Milpied, N.-J. et al.
Source: Self-asserted source
Joshua Fein via Scopus - Elsevier

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy

Nature Communications
2017 | Journal article
EID:

2-s2.0-85038627612

Contributors: Landau, D.A.; Sun, C.; Rosebrock, D.; Herman, S.E.M.; Fein, J.; Sivina, M.; Underbayev, C.; Liu, D.; Hoellenriegel, J.; Ravichandran, S. et al.
Source: Self-asserted source
Joshua Fein via Scopus - Elsevier

Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort

American Journal of Hematology
2017 | Journal article
EID:

2-s2.0-85013388427

Contributors: Shouval, R.; Bonifazi, F.; Fein, J.; Boschini, C.; Oldani, E.; Labopin, M.; Raimondi, R.; Sacchi, N.; Dabash, O.; Unger, R. et al.
Source: Self-asserted source
Joshua Fein via Scopus - Elsevier

Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?

Biology of Blood and Marrow Transplantation
2017-11 | Journal article
Contributors: Rashmika Potdar; Gabor Varadi; Joshua Fein; Myriam Labopin; Arnon Nagler; Roni Shouval
Source: check_circle
Crossref

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Blood
2016 | Journal article
EID:

2-s2.0-84978389613

Contributors: Lampson, B.L.; Kasar, S.N.; Matos, T.R.; Morgan, E.A.; Rassenti, L.; Davids, M.S.; Fisher, D.C.; Freedman, A.S.; Jacobson, C.A.; Armand, P. et al.
Source: Self-asserted source
Joshua Fein via Scopus - Elsevier

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism

Blood
2016 | Journal article
EID:

2-s2.0-84977263866

Contributors: Anderson, M.A.; Deng, J.; Seymour, J.F.; Tam, C.; Kim, S.Y.; Fein, J.; Yu, L.; Brown, J.R.; Westerman, D.; Si, E.G. et al.
Source: Self-asserted source
Joshua Fein via Scopus - Elsevier

Peer review (11 reviews for 1 publication/grant)

Review activity for Bone marrow transplantation (11)